dipyridamole has been researched along with Berger Disease in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (26.83) | 18.7374 |
1990's | 11 (26.83) | 18.2507 |
2000's | 14 (34.15) | 29.6817 |
2010's | 4 (9.76) | 24.3611 |
2020's | 1 (2.44) | 2.80 |
Authors | Studies |
---|---|
Hachiya, A; Matsuoka, D; Motoki, N; Shimada, S; Tsukahara, T | 1 |
Hataya, H; Honda, M; Iijima, K; Ishikura, K; Kaku, Y; Matsuyama, T; Nakanishi, K; Nozu, K; Sako, M; Shima, Y; Tanaka, R; Yoshikawa, N | 1 |
Yoshikawa, N | 1 |
Iijima, K; Kamei, K; Nakanishi, K; Nozu, K; Sasaki, S; Shima, Y; Tanaka, R; Togawa, H; Yoshikawa, N | 1 |
Hataya, H; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kamei, K; Nakanishi, K; Saito, M; Sako, M; Yoshikawa, N | 1 |
Brodsky, SV; Hebert, LA; Rovin, BH | 1 |
Arisaka, O; Kano, K; Nishikura, K; Yamada, Y | 1 |
Tang, X | 1 |
Ikeda, M; Kuwajima, H; Okada, M; Sugimoto, K; Takemura, T; Yagi, K; Yanagida, H | 1 |
Arisaka, O; Kano, K; Nishikura, K | 1 |
Gejyo, F; Hiura, T; Kawabe, S; Miyamura, S; Nishi, S; Saeki, T; Ueno, M; Yamazaki, H | 1 |
Li, SM; Yan, JX; Yang, L | 1 |
Locatelli, F; Pozzi, C; Vecchio, LD | 1 |
Kuwahara, T; Morimoto, T; Shikata, S; Taji, Y | 1 |
Awazu, M; Hattori, S; Honda, M; Iijima, K; Ito, H; Nakanishi, K; Yoshikawa, N | 1 |
Iitaka, K; Ishikawa, Y; Kojima, Y; Motoyama, O; Ohara, A; Tsukimoto, I | 1 |
Hataya, H; Honda, M; Iijima, K; Ishikura, K; Nakanishi, K; Yoshikawa, N | 1 |
Akano, N; Aya, N; Hino, S; Maki, S; Miyazato, H; Murakami, K; Okada, M; Takemura, T; Yagi, K; Yoshioka, K | 1 |
Horigome, I; Hotta, O; Kurosawa, K; Sudo, K; Suzuki, K; Taguma, Y | 1 |
Hiki, Y; Horii, A; Kobayashi, Y; Kokubo, T; Tateno, S | 1 |
Awazu, M; Hattori, S; Honda, M; Iitaka, K; Ito, H; Ito, K; Koitabashi, Y; Matsuyama, S; Nakagawa, K; Nakamura, H; Ninomiya, M; Sakai, T; Seino, Y; Takeda, N; Takekoshi, Y; Yamaoka, K; Yoshikawa, N | 1 |
Ito, H; Yoshikawa, N | 1 |
Lee, GS; Pall, AA; Woo, KT | 1 |
Fujieda, M; Kinoshita, A; Kurashige, T; Moriki, T; Nakayama, T; Naruse, K; Wakiguchi, H | 1 |
Ye, RG | 1 |
Higuchi, M; Itoh, N; Miyasaka, M; Moriya, T; Nakazawa, K; Oguchi, H; Shigematsu, H | 1 |
Lee, GS; Woo, KT | 1 |
Chiang, GS; Lau, YK; Lee, GS; Lim, CH; Woo, KT | 1 |
Kincaid-Smith, P; Owen, JE; Walker, RG; Yu, SH | 1 |
Górski, A; Lao, M; Małdyk, M; Morzycka-Michalik, M; Orłowski, T; Rancewicz, Z; Smogorzewski, M; Szczesny-Nowicka, B | 1 |
Lee, GS; Lim, CH; Woo, KT | 1 |
Fujii, K; Hiki, Y; Kobayashi, Y; Kurokawa, A; Tateno, S | 1 |
Endoh, M; Miura, M; Nomoto, Y; Sakai, H; Suga, T; Tomino, Y; Yagame, M | 1 |
Berry, A; McAdams, AJ; Welch, TR | 1 |
Hanzawa, S; Kitajima, T; Ohno, J; Sakai, H; Sakai, O; Tomino, Y | 1 |
Chiang, GS; Lim, CH; Woo, KT; Yap, HK | 1 |
Chiang, GS; Lim, CH; Woo, KT | 1 |
Chiang, GS; Lau, YK; Lim, CH; Woo, KT | 1 |
Chiang, GS; Edmondson, RP; Lee, EJ; Lim, CH; Pwee, HS; Woo, KT; Wu, AY; Yap, HK | 1 |
Chan, KW; Chan, MK; Kwan, SY; Yeung, CK | 1 |
Ito, S; Kawaguchi, S; Niinomi, Y; Nonoda, T; Ohnishi, M; Ueda, N; Yasaki, T | 1 |
5 review(s) available for dipyridamole and Berger Disease
Article | Year |
---|---|
[Treatment of childhood IgA nephropathy].
Topics: Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Glomerulonephritis, IGA; Heparin; Humans; Practice Guidelines as Topic; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Ribonucleosides; Warfarin | 2008 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progression; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Heparin; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Glomerulus; Male; Prednisolone; Proportional Hazards Models; Prospective Studies; Proteinuria; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Warfarin | 2011 |
Nephrotic syndrome and IgA nephropathy in polycystic kidney disease.
Topics: Aged; Biopsy; Dipyridamole; Glomerulonephritis, IGA; Humans; Kidney; Losartan; Male; Nephrotic Syndrome; Polycystic Kidney, Autosomal Dominant; Prednisolone; Thiazepines | 2006 |
IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dipyridamole; Disease Progression; Drug Therapy, Combination; Fish Oils; Glomerulonephritis, IGA; Glucocorticoids; Humans; Platelet Aggregation Inhibitors; Proteinuria; Tonsillectomy; Treatment Outcome | 2006 |
Meta-analysis of antiplatelet therapy for IgA nephropathy.
Topics: Dilazep; Dipyridamole; Glomerulonephritis, IGA; Humans; Kidney Function Tests; Platelet Aggregation Inhibitors; Proteinuria; Trimetazidine | 2006 |
17 trial(s) available for dipyridamole and Berger Disease
Article | Year |
---|---|
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Topics: Adolescent; Biopsy; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome; Warfarin | 2018 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progression; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Heparin; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Glomerulus; Male; Prednisolone; Proportional Hazards Models; Prospective Studies; Proteinuria; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Warfarin | 2011 |
Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
Topics: Adolescent; Child; Dipyridamole; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Glomerulonephritis, IGA; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney; Male; Prospective Studies; Proteinuria; Vasodilator Agents | 2003 |
[Effect of ligustrazine on proliferative glomerulonephritis].
Topics: Adolescent; Adult; Creatinine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fibrinolytic Agents; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Losartan; Male; Middle Aged; Prednisone; Pyrazines; Serum Albumin | 2003 |
Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Topics: Adolescent; Adult; Age of Onset; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney; Male; Prednisone; Proteinuria; Ribonucleosides; Treatment Outcome; Vasodilator Agents | 2003 |
[Effects of Astragalus injection on renal tubular function in patients with IgA nephropathy].
Topics: Adolescent; Adult; Astragalus propinquus; Benzazepines; Dipyridamole; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glomerulonephritis, IGA; Humans; Injections, Intravenous; Kidney Tubules; Male; Middle Aged; Phytotherapy | 2006 |
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Topics: Azathioprine; Child; Dipyridamole; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; Prednisolone; Prospective Studies; Severity of Illness Index; Warfarin | 2006 |
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Topics: Biopsy; Child; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Glomerulus; Male; Pilot Projects; Platelet Aggregation Inhibitors; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2008 |
Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Indomethacin; Kidney; Kidney Function Tests; Male; Platelet Aggregation Inhibitors; Prednisolone; Retrospective Studies; Survival Rate; Treatment Outcome | 1996 |
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Topics: Adolescent; Azathioprine; Blood Urea Nitrogen; Child; Dipyridamole; Drug Therapy, Combination; Glomerular Mesangium; Glomerulonephritis, IGA; Hematuria; Heparin; Humans; Immunoglobulin A; Microscopy, Fluorescence; Prednisolone; Proteinuria; Warfarin | 1999 |
Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Topics: Adult; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis, IGA; Glucocorticoids; Heparin; Humans; Immunosuppressive Agents; Platelet Aggregation Inhibitors; Prednisolone; Warfarin | 1999 |
Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Topics: Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Kidney Function Tests; Male; Prospective Studies; Time Factors; Warfarin | 1991 |
The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Topics: Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Male; Prospective Studies; Time Factors; Warfarin | 1990 |
Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
Topics: Adult; Clinical Trials as Topic; Dipyridamole; Female; Glomerulonephritis, IGA; Humans; Male; Nephritis; Warfarin | 1989 |
Clinical effect of danazol in patients with IgA nephropathy.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Complement C3; Complement C4; Danazol; Dipyridamole; Glomerulonephritis, IGA; Hematuria; Humans; Japan; Male; Pregnadienes; Proteinuria | 1987 |
Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Topics: Adult; Clinical Trials as Topic; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis; Glomerulonephritis, IGA; Humans; Male; Prospective Studies; Time Factors; Warfarin | 1987 |
Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Topics: Adult; Aspirin; Blood Platelets; Clinical Trials as Topic; Creatinine; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin G; Male; Random Allocation | 1987 |
20 other study(ies) available for dipyridamole and Berger Disease
Article | Year |
---|---|
Myocardial ischemia during methylprednisolone pulse therapy with dipyridamole.
Topics: Dipyridamole; Glomerulonephritis, IGA; Humans; Methylprednisolone; Myocardial Ischemia; Pulse Therapy, Drug | 2021 |
Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Topics: Anti-Inflammatory Agents; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Glomerulus; Male; Prednisolone; Retrospective Studies; Ribonucleosides; Survival Rate; Treatment Outcome; Vasodilator Agents; Warfarin | 2011 |
Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
Topics: Acute Kidney Injury; Adult; Child; Cohort Studies; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Male; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Treatment Outcome; Warfarin | 2012 |
Does growth hormone therapy induce IgA nephropathy?
Topics: Child, Preschool; Dipyridamole; Follow-Up Studies; Glomerulonephritis, IGA; Growth Hormone; Humans; Immunoglobulin A; Male; Recombinant Proteins; Time Factors; Treatment Outcome | 2005 |
IgA nephropathy associated with leukemia and lymphoma: report of two cases.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dipyridamole; Female; Glomerulonephritis, IGA; Hematuria; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Glomerulus; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2008 |
Combined therapy in children and adolescents with IgA nephropathy.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Male; Prednisolone; Retrospective Studies; Warfarin | 1994 |
Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
Topics: Adolescent; Adult; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Hematuria; Humans; Male; Middle Aged; Proteinuria; Remission Induction; Tonsillectomy; Warfarin | 1993 |
Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
Topics: Anticoagulants; Cyclophosphamide; Dipyridamole; Dose-Response Relationship, Drug; Glomerulonephritis, IGA; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Warfarin | 2000 |
Mumps associated with immunoglobulin A nephropathy.
Topics: Antibodies, Viral; Biopsy; Child, Preschool; Dipyridamole; Enzyme-Linked Immunosorbent Assay; Glomerulonephritis, IGA; Hemagglutination Inhibition Tests; Humans; Immunoglobulin M; Kidney; Male; Mumps; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Viral; Rubulavirus | 2000 |
[Treatment of IgA nephropathy by integrated traditional and Western medicine].
Topics: Adolescent; Adult; Child; Child, Preschool; Dipyridamole; Drugs, Chinese Herbal; Female; Glomerulonephritis, IGA; Humans; Male; Middle Aged | 1992 |
A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Topics: Adolescent; Basement Membrane; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Furosemide; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Prednisolone; Warfarin | 1992 |
The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
Topics: Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Warfarin | 1991 |
IgA nephropathy: a long-term progressive study.
Topics: Adolescent; Adult; Aspirin; Child; Creatinine; Dipyridamole; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Prospective Studies | 1990 |
Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Dipyridamole; Female; Glomerulonephritis, IGA; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Proteinuria | 1989 |
Clinical effect of dipyridamole in patients with IgA nephropathy.
Topics: Adrenochrome; Dipyridamole; Glomerulonephritis; Glomerulonephritis, IGA; Hematuria; Humans; Proteinuria | 1986 |
Rapidly progressive IgA nephropathy.
Topics: Adolescent; Child; Complement C3; Complement C4; Dipyridamole; Female; Glomerulonephritis, IGA; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Prednisone; Renal Dialysis | 1988 |
Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
Topics: Biopsy, Needle; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Prospective Studies; Warfarin | 1988 |
Follow-up renal biopsies in IgA nephritic patients on triple therapy.
Topics: Biopsy, Needle; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Kidney; Random Allocation; Warfarin | 1987 |
IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
Topics: Adult; Age Factors; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Male; Prognosis; Sex Factors; Singapore; Time Factors; Warfarin | 1987 |
Effect of dipyridamole treatment on proteinuria in pediatric renal disease.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Dipyridamole; Female; Glomerulonephritis; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Male; Proteinuria | 1986 |